Guyana vs Jordan: Hepatitis B surface antigen (HBsAg) prevalence
Guyana
0.1%
in 2024
Jordan
0.1%
in 2024
Guyana rank
101st
Jordan rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Guyana
- Jordan
How they compare
Guyana currently reports 0.1% against 0.1% in Jordan, a difference of 0.0%.
Across all 10 years both countries report, Jordan has been ahead every year.
Guyana ranks 101st and Jordan ranks 101st of 194 countries.
Head to head by decade
| Decade | Guyana | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | — |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Guyana or Jordan?
- Guyana, at 0.1% against 0.1% in Jordan as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Guyana and Jordan?
- 0.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Jordan?
- 10 years are reported by both, from 2015 to 2024.
- How do Guyana and Jordan rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Guyana ranks 101st and Jordan ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.